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Abstract 
In this study, 18 mushrooms were collected from Gandhi Krishi Vigyana Kendra (GKVK) 
campus, University of Agricultural Sciences, Bangalore (India) and identified by Internal 
Transcribed Spacer (ITS) region using National Centre for Biotechnology Information 
(NCBI) data base and screened for antibacterial property against two skin infection 
causing bacteria viz.,Pseudomonas aeruginosa and Staphylococcus aureus in dogs. 
Eleven mushrooms extract inhibited both the bacteria showing their antimicrobials as 
broad spectrum while inhibiting gram positive as well as gram negative bacteria.  The 
highest zone of inhibition was recorded from the extract of Lyophyllum sp. The extract of 
two mushrooms viz., Phlebopus portentosus and Termitomyces sp. inhibited only P. 
aeruginosa, a gram negative bacterium  and the extract of three mushrooms viz., Agari-
cus sp, Coprinellus disseminates and Agaricus blazei inhibited only S. aureus, a gram 
positive bacterium, suggesting spectral specificity of their antimicrobial compounds.  
However,  the extracts of two mushrooms viz.,Macrocybe gigantea and Schizophyllum 
commune did not show inhibition of any of the pathogens.  Hence, this study suggests 
that the occurrence of potential pharmaceuticals in mushrooms can be exploited for 
control of multidrug resistant bacteria. 
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INTRODUCTION 
Mushrooms are macro-fungi with a distinctive 
fruiting body, that can be either hypogeous or epi-
geous, large enough to be seen by the naked eye 
and to be picked up by hand (Chang and Miles, 
1992).  Mushrooms produce antibacterial and  
antifungal compounds to survive in their natural 
environment. It is therefore not surprising that an-
timicrobial compounds with more or less strong 
activities could be isolated from mycelia or fruiting 
body which are useful for human health 
(Lindequist et al., 1990).  Mushrooms are superior 
nutritional supplement but attributed with magnifi-
cent medicinal values too. The bioactive com-
pounds present in mushroom includes, polysac-
charides, lipopolysaccharides, proteins, peptides, 
glycoproteins, nucleosides, triterpenoids, lectins, 
lipids and their derivatives (Sharma et al., 2014).  
Fruiting bodies, mycelia, and spores accumulate a 
variety of bioactive metabolites with immunomod-
ulatory, cardiovascular, liver protective, antifibrot-
ic, anti-inflammatory, antidiabetic, antiviral, antiox-
idant, antitumor, and antimicrobial properties. 
Staphylococcus aureus is a Gram-positive coccus 
that are commonly found on the skin of most 
mammals. These bacteria are able to produce and 
secrete numerous cell products that cause severe 
tissue damage. Staphylococci are also particularly 
adept at avoiding the effects of antibiotics. In par-
ticular, methicillin-resistant Staphylococci have 
emerged as a serious medical problem and they 
are able to develop and transfer resistance to nu-
merous antibiotics by means of several divergent 
mechanisms (Upadhyay, 2011) 
 Pseudomonas aeruginosa is an opportunistic 
Gram negative pathogen of both human and vet-
erinary species. This bacterium almost never af-
fects healthy tissue but prefers damaged or dis-
eased regions of the skin. In dogs, Pseudomonas 
otitis is the principal disease process caused by 
this organism. It is likely that the chronic altera-
tions in the otic microenvironment associated with 
persistent inflammation, sets up a state of hyperhi-
drosis. The unique pathogenicity of Pseudomonas 
allows it to take advantage of the diseased tissue 
and develop resistance to antibiotics (Cholley et 
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al., 2010). 
The drug resistant patterns of the pathogens in 
community health settings are worrisome as most 
of these resistant bacteria are capable of horizon-
tal gene transfer, decreased cell permeability 
against conventional antibiotics, and alteration of 
the ribosomal binding site (Adwan et al., 2014). 
Thus, the problem of antibiotic resistance is now 
become a global challenge in both under devel-
oped and developing countries (Levy, 2002; Sosa 
et al., 2010). The bacterial pathogens, P. aeru-
ginosa and S. aureus are causing skin infection in 
animals and they are posing resistant to chemical-
ly synthesized antibiotics. In order to curb the 
problem of antibiotic resistances, the use of bio-
logically active compounds originated from plants 
and fungi are necessary. The health-promoting 
benefits of secondary metabolites sourced from 
medicinal mushrooms had tremendously in-
creased and the chances of obtaining novel and 
safe antimicrobial compounds, which would com-
bat and reduce the incidence of antibiotic re-
sistance (Alves et.al., 2012).  Therefore, we at-
tempted to explore the antibacterial mushrooms 
against Pseudomonas aeruginosa and Staphylo-
coccus aureus.   
MATERIALS AND METHODS 
Molecular identification using ITS region  
sequence: During rainy season (July-September 
2016), fruiting bodies of 18 wild mushrooms were 
collected from different locations at GKVK 
(Gandhi Krishi Vigyana Kendra) campus, Univer-
sity of Agricultural Sciences, Bengaluru-560065. 
The genomic DNA was extracted from tissue by 
modified CTAB (Cetyl Trimethyl Ammonium Bro-
mide) lysis method (Doyle and Doyle, 1987). Fruit-
ing body (0.1 g) was ground with extraction buffer 
(1.5 ml) containing CTAB, mixed with PVP and ß 
mercapto ethanol and incubated at 65 °C for 45 
minutes.  Half of the sample was transferred into a 
new tube and equal volume of chloroform: isoamyl 
alcohol (24:1) was added.  They were centrifuged 
at 10,000 rpm for 10 minutes and the supernatant 
was transferred into a new tube. The DNA was 
precipitated by adding 600 µl of chilled isopropa-
nol and centrifuged at 10,000 rpm after overnight 
incubation. The pellet was washed with of 70 % 
chilled ethanol, air dried and dissolved in 20-25 µl 
of double distilled water. The Ribo Nucleic Acid 
(RNA) was removed by adding 5 µl of RNase and 
incubated at 37 °C for one hour. The purity and 
concentration the DNA was checked at 260 nm 
using BioMATE 3S UV-Visible spectrophotometer 
(Thermo Fisher Scientific, USA). 
Genomic DNA was PCR amplified using 40 µl 
reaction mixture containing 4.0 µl 10x Taq. Buffer, 
4.0 µl 10mM dNTP mixture, 2.0 µl ITS Primers, 
0.6 µl Taq. DNA polymerase, 2.0 µl Template 
DNA, 27.4 µl sterile distilled water (Sambrook et 
al., 1989). The PCR was carried out in a thermal 
cycler programmed as follows. Initial denaturation 
at 94 °C for 4 min. 35 cycles of denaturation at 94 
°C for 1 min, annealing at 60 °C for 30 secs, ex-
tension at 72 °C for 1 min and final extension at 
72 °C for 10 min. The amplified products were 
separated by agarose gel (1 %) electrophoresis.  
Then the DNA was eluted from the agarose gel 
using gel extraction kit (Gene JET™ Gel Extrac-
tion Kit,Thermo Scientific) and the eluted DNA 
was got sequenced by Scigenom Labs Pvt. Ltd, 
India using ITS1 and ITS4  primers.   Sequence 
results were analyzed with online software (http://
www.ncbi.nlm.nih.gov/BLAST) of National Centre 
for Biotechnology (NCBI) (Altschul et al., 1990). 
Preparation of mushroom extract and screen-
ing for antibacterial property: One gram of fresh 
tissue from the fruiting body was washed, surface 
sterilized using 5% Sodium hypochlorite solution 
and repeatedly washed with sterile water.  The 
tissue was crushed in 5ml sterile water using pes-
tle and mortar to obtain 20 % aqueous extract (1g 
in 5 ml). The extract was centrifuged and superna-
tant was collected.  The extract thus obtained was 
filter sterilized using 0.22 µ membrane filters at-
tached to sterile disposable syringes. The extracts 
were collected in sterile eppendorff tubes and 
stored at -20 °C (Blue star, CHF 100B). The sterile 
water was used as control.  The two bacteria viz., 
P. aeruginosa and S. aureus isolated from dog’s 
otitis infection and dermatitis (Fig.1 ) from the In-
stitute of Animal Health and Veterinary Biologicals 
(IAH abd VB), Karnataka Veterinary, Animal and 
Fisheries Sciences University (KVAFSU), Banga-
lore-560024 were obtained and cultured on Brain 
Heart Infusion Agar and Mannitol Salt Agar re-
spectively. 
The bacterial lawn was prepared on solidified nu-
trient agar medium. Sterile filter paper discs 
(Whatman No. 42) of 5 mm diameter were dipped 
in 20 % mushroom extracts and placed on the 
lawn of the test organisms. Three filter paper discs 
have been used for each mushroom extract. The 
filter paper disc dipped in sterile water was used 
as control on the lawn.  These plates were incu-
bated at 37 °C.  The observation for inhibition 
zone was recorded after 24 hours.  The minimum 
inhibitory concentration was determined by using 
different concentrations.  
RESULTS AND DISCUSSION 
Molecular identification: Mushrooms can be 
identified by both phenotypic and molecular char-
acters. The morphological characters alone used 
in the classification are time consuming and often 
inadequate for exact strain identification. Morpho-
logical characterization also needs basic 
knowledge on the structure or phenotypic charac-
ters of mushrooms (Arora, 1986).  However, in 
recent years, the molecular approach by using 
Mariselvi  M. and Earanna N. / J. Appl. & Nat. Sci. 10 (2): 791– 796 (2018) 
 793 
Internal Transcribed Spacer (ITS) region/ 18S 
rRNA gene sequence are used for identification of 
mushrooms including other eukaryotes, as these 
sequences are conserved irrespective of life histo-
ry and evolution (Rajaratnam and Thiagarajan, 
2012). The internal transcribed spacer (ITS) re-
gion of the ribosomal DNA (rDNA) has been wide-
ly used for identification of mushrooms at both 
species and genus level (Sanchez-Ballesteros et 
al., 2000).  The ITS region fragment ranges be-
tween 450 to 700 base pair has the highest proba-
bility of successful identification for the broadest 
range of fungi, with the most clearly defined gap 
between inter- and intra-specific variation (Schoch 
et al., 2012). In the present study, eighteen mush-
rooms collected from different location of the cam-
pus were designated as GKVK-1, GKVK-2, GKVK-
3, GKVK-4, GKVK-5, GKVK-6, GKVK-7, GKVK-8, 
GKVK-9, GKVK-10, GKVK-11, GKVK-12, GKVK-
13, GKVK-14, GKVK-15, GKVK-16, GKVK-17 and 
GKVK-18 were identified up to species level by 
using ITS rRNA region sequence.  The PCR am-
plification of genomic DNA of the eighteen mush-
rooms in the present study yielded amplified prod-
uct size varying from 440 to 1054 bp which are 
corresponding to almost full length gene sequence 
of ITS rRNA. The sequence homology of the 
eighteen species ranged from 87-99 per cent 
when aligned with the sequences present in NCBI 
(http://www.ncbi.nlm.nih.gov/BLAST) (Altschul et 
al., 1990). The mushroom designated as GKVK-1 
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Fig.1.A. Dog’s ear infection.  B. Inhibition zone aused 
by mushroom extract C. Colonies of P. aeruginosa.  
D.  Colonies of S. aureus.  
Fig.2. Partial sequence length and homology search 
of Lepista sordida (GKVK-1) 
Table 1. Effect of aqueous extract of mushrooms on P. aeruginosa and S. aureus. 
Mushrooms 
Diameter of inhibition zone (mm) 
P. aeruginosa S. aureus 
Control (sterile water) 0.00f 0.00g 
Lepista sordida 7.33a 8.50a 
Lyophyllum sp. 6.17de 5.83ef 
Psathyrella candolleana 7.17ab 7.50bc 
Lepiota sp. 6.67bcd 6.50def 
Macrocybe gigantea 0.00f 0.00g 
Agaricus xanthodermus 6.17de 7.50bc 
Agaricus sp. 6.17de 7.67ab 
Hymenagaricus sp. 6.83abc 6.17ef 
Ganoderma multipileum 7.33a 6.67cde 
Agaricus sp. 0.00f 7.33bcd 
Schizophyllum commune 0.00f 0.00g 
Agrocybe pediades 6.17de 6.67cde 
Phlebopus portentosus 6.00e 0.00g 
Omphalotus olivascens 6.33cde 7.17bcd 
Coprinellus disseminatus 0.00f 7.33bcd 
Termitomyces sp. 6.67bcd 0.00g 
Geastrum sp. 6.33cde 6.50def 
Agaricus blazei 0.00f 5.67f 
S. Em± 0.187 0.296 
LSD @ 5 % 0.536 0.848 
Means of the same superscript in a column do not differ significantly @ P = <0.05  as per Duncan Multiple 
Range Test 
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showed 99 percent homology to Lepista sordida  
(Fig.2), GKVK-2 with 98% to Lyophyllum sp., 
GKVK-3 with 95% to Psathyrella candolleana, 
GKVK-4 with 95% to Lepiota sp., GKVK-5 with 
99% to Macrocybe gigantean, GKVK-6  with 97% 
to Agaricus xanthodermus,GKVK-7 with 99% to 
Agaricus sp., GKVK-8 with 87% to Hymenagari-
cus sp., GKVK-9 with 99% to Ganoderma multipi-
leum, GKVK-10  with 95% to Agaricus sp., GKVK-
11 with 98% to Schizophyllum commune, GKVK-
12 with 99% to Agrocybe pediades,  GKVK-13 
with 99% to Phlebopus portentosus, GKVK-14  
with 99% to Omphalotus olivascens,GKVK-15  
with 98% to Coprinellus disseminates, GKVK-16 
with 98% to Termitomyces sp., GKVK-17 with 
97% to Geastrum sp., and the GKVK-18 has 99% 
homology with Agaricus blazei (Fig.3, A-R, shows 
the fruit bodies of 18 identified mushrooms).  Iden-
tification of mushrooms using ITS region se-
quence is advantageous as organism can be 
identified at any stages of the growth and it is 
widely used for identification several fungi 
(Schoch et. al., 2012).  Raju et al. (2014) identified 
Volveriella species by PCR amplification of ITS 
region using ITS 1 and ITS 4 primers. Similarly, 
fourteen mushroom species including Termitomy-
ces documented from Biligiri Rangana Hills of 
Westernghats of Karnataka were identified by ITS 
region sequence (Akash et al., 2017).   
Effect of mushrooms extract on pathogens: 
Antimicrobial property of mushrooms due to the 
presence of antibiotics, tannins, alkaloids, flavo-
noids etc.(Draughon,2004).  Out of eighteen wild 
mushroom extracts screened, eleven showed ef-
fective in inhibiting both the bacteria (Table,1).  
Significantly highest zone of inhibition was ob-
served for Lepista sordida.  The diameter of inhibi-
tion zone of this mushroom was 7.33 mm and 
8.50 mm for P aeruginosa and S aureus respec-
tively. The next best was the Psathyrella candolle-
ana which caused 7.17 mm and 7.50 mm diame-
ter of inhibition zone for P. aeuruginosa and S 
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Fig. 3. Mushrooms identified and screened for antibacterial property.     A- Lepista sordida, B- Lyophyllum sp., 
C- Psathyrella candolleana, D- Lepiota sp., E- Macrocybe gigantea, F- Agaricus xanthodermus, G- Agaricus 
sp., H- Hymenagaricus sp., I- Ganoderma multipileum, J- Agaricus sp., K- Schizophyllum commune, L- Agrocy-
be pediades, M- Phlebopus portentosus, N- Omphalotus olivascens, O- Coprinellus disseminatus, P- Termito-
myces sp., Q-Geastrum sp., R- Agaricus blazei 
A B C D 
E F G H 
I J K L 
M N O P 
Q R 
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aureus respectively.   Rest of the mushroom spe-
cies showed varied inhibition zone for each patho-
gen.  This indicates that these mushrooms in gen-
eral contain antibacterial compounds that are 
probably broad spectrum ones and efficacy varied 
with mushroom species. The variations in the anti-
microbial activities of mushrooms may be due to 
the differences in their bioactive compositions or 
concentrations, methods of extraction and mecha-
nism of action of active ingredients present in the-
se mushrooms (Iwalokun et al., 2007).  Further, 
the extracts of two mushrooms (Phlebopus por-
tentosus and Termitomyces sp.) inhibited only P. 
aeruginosa and three mushrooms viz., Agaraicus 
sp., Coprinellus disseminates and Agaricus blazei 
inhibited only S. aureus.  This variation in antimi-
crobial activities of mushrooms may be due the 
differences in their bioactive compositions or con-
centrations, methods of extraction and mecha-
nism of action of anti-ingredients in mushrooms 
(Iwalokun et al., 2007) as P. aeruginosa is a gram 
negative and S. aureus is a gram positive bacte-
ria.  Quang et al. (2006) reported that the benzoic 
acid derivative isolated from mushroom Xylaria 
intracoiarata showed antibacterial activity against 
only gram negative bacteria viz., Escherichia coli, 
Psiudomonas aeuroginosa and Solmonella enter-
itidis. 
Two mushrooms viz., Macrocybe gigantea and 
Schizophyllum commune did not show any inhibi-
tion on either bacterium.  These mushrooms might 
not have produce antibacterial against the target-
ed pathogens.  Otherwise, method of extraction 
may also influence  because, in earlier studies,  
ethanol extract of Ganoderma lucidum did not 
inhibit Staphylococcus aureus, Bacillus, Alcali-
genes faecalis, and Proteus vulgaris but, ben-
zene, chloroform, and ethyl acetate extracts gave 
better results on inhibition of test organisms 
(Shikongo et al. 2013).  Beattie et al. (2010) also 
reported the efficacy of ethyl acetate extract of the 
mushrooms viz., Cortinarius ardesiacus, C. arch-
eri, C. atrosanguineus, C. austrovenetus, C. aus-
troviolaceus, C. coelopus, C. clelandii, C. memoria
-annae, C. persplendidus, C. sinapicolor, C. vi-
nosipes  on inhibition of Staphylococcus aureus.   
The minimal inhibitory concentration (MIC) of 
mushrooms extract varied between two patho-
gens.  MIC ranged between 0.2% to 16% for P. 
aeruginosa (Table,2, Fig.1B).  Least concentration 
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Table 2. Minimum inhibitory concentration of mushroom extracts against P. aeruginosa 
Mushrooms 
Per cent concentration 
20 18 16 14 12 10 8 6 4 2 1 0.8 0.6 0.4 0.2 0.09 
Lepista sordida + + + + + + + + + + + + + + + - 
Lyophyllum sp. + + + - - - - - - - - - - - - - 
Psathyrella candolleana + + + + + + + + + + + + + + - - 
Lepiota sp. + + + + + + + + + + + + + - - - 
Agaricus xanthodermus + + + + + + + + + + + + + - - - 
Agaricus sp. + + + + + + + + + + + + + + - - 
Hymenagaricus sp. + + + + - - - - - - - - - - - - 
Ganoderma multipileum + + + + + + + + + - - - - - - - 
Agaricus sp. + + + + + + + + + + + + + - - - 
Agrocybe pediades + + + + + + + + - - - - - - - - 
Omphalotus olivascens + + + + + + + + + - - - - - - - 
Coprinellus disseminatus + + + + + + + + + + + + + - - - 
Geastrum sp. + + + + - - - - - - - - - - - - 
Agaricus blazei + + + - - - - - - - - - - - - - 
+ = positive for inhibition zone; - = negative for inhibition zone 
Table 3. Minimum inhibitory concentration of mushroom extracts on S. aureus. 
Mushrooms 
Per cent concentration 
20 18 16 14 12 10 8 6 4 2 1 0.8 0.6 0.4 0.2 
Lepista sordida + + + + + + + + + + + + - - - 
Lyophyllum sp. + + + + + - - - - - - - - - - 
Psathyrella candolleana + + + + + + + + + + + + + + - 
Lepiota sp. + + + + + + + + + + + + + + - 
Agaricus xanthodermus + + + + - - - - - - - - - - - 
Agaricus sp. + + + - - - - - - - - - - - - 
Hymenagaricus sp. + + + + + + + + - - - - - - - 
Ganoderma multipileum + + + + + + + + + + + + + - - 
Agrocybe pediades + + + + - - - - - - - - - - - 
Phlebopus portentosus + + + - - - - - - - - - - - - 
Omphalotus olivascens + + + + + + + + + - - - - - - 
Termitomyces sp. + + + + + + + + + - - - - - - 
Geastrum sp. + + + - - - - - - - - - - - - 
+ = positive for inhibition zone: - = negative for inhibition zone 
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of L. sordida extract being 2 percent showed inhi-
bition of P. aeruginosa indicating its potentiality at 
minimal concentration.  Similarly, the extract of 
mushrooms P. candolleana and Lepiota sp. 
showed 0.4% as MIC against S. aureus (Table,3).  
This suggest that the antimicrobial present in dif-
ferent mushrooms and their mode of action  may 
differ for different pathogen.  Kolundzic and Mari-
na (2016)  reported that the antibacterial activity of 
aqueous extracts of tinder fungus Fomes fomen-
tarius against Helicobacter pylori with MIC values 
between 4-30 µg/ml.    
Conclusion 
In our study, 16 mushroom species exhibited anti-
bacterial activity against P. aeruginosa and S. 
aeurus.  Though the inhibition pattern varied for 
different mushroom species, all 16 mushrooms 
can be exploited for isolation of pure compounds 
to use against multi drug resistant pathogens as 
only crude extracts were used in this study.  
Among 16 mushroom species, the L. sordida 
showed maximum inhibition zone against both 
bacteria.  Therefore, L. sordida would be the best 
mushroom for antibacterial compounds compared 
to others. Further, P. portentosus and Termitomy-
ces sp can be exploited for controlling gram nega-
tive bacteria as they specifically inhibited P. aeru-
ginosa but not S aureus.  Similarly, Agaricus sp,  
Agaricus blazei  and Coprinellus disseminates 
were more efficient against gram positive bacteria 
as they inhibited S. aureus alone.  
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